Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

NCT02723331 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer
Pancreatic Adenocarcinoma
Pancreas Ductal Adenocarcinoma

Interventions

DRUG: Nab paclitaxel
DRUG: Gemcitabine

Sponsor

Academic Thoracic Oncology Medical Investigators Consortium

Collaborators

[object Object]
[object Object]
[object Object]